During the past decade, Consultants in Neurology, Ltd. conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 13 clinical trials were completed, i.e. on average, 86.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 7 clinical trials were completed. i.e. 70% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Consultants in Neurology, Ltd." #1 sponsor was "Celgene" with 5 trials, followed by "Avanir Pharmaceuticals" with 4 trials sponsored, "Genzyme, a Sanofi Company" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Acorda Therapeutics" with 4 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Consultants in Neurology, Ltd." #1 collaborator was "Bayer" with 4 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator, "Elan Pharmaceuticals" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Consultants in Neurology, Ltd." are "Multiple Sclerosis" (14 trials), "Multiple Sclerosis, Relapsing-Remitting" (9 trials), "Relapsing Multiple Sclerosis" (2 trials), "ADHD" (1 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Consultants in Neurology, Ltd." in a lesser frequency.

Most popular intervention types in "Consultants in Neurology, Ltd." are "Drug" (29 trials), "Biological" (9 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Interferon beta-1a" (6 trials), "Ocrelizumab" (4 trials), "AVP-923" (2 trials) and "Alemtuzumab 12 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Consultants in Neurology, Ltd." are 38 trials for "All" genders.

Currently, there are NaN active trials in "Consultants in Neurology, Ltd.". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Consultants in Neurology, Ltd., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Consultants in Neurology, Ltd., 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".